MindSave Official Website › Notebook › Two Vitamins On Your Cognition Label Have Upper Limits. Add Them Up.

Two Vitamins On Your Cognition Label Have Upper Limits. Add Them Up.

By MindSave Team · Last updated October 29, 2026 · 8 min read · Cognition labels · Reviewed by Dr. Ariel Frankel, PhD

Most arguments about supplement amounts are about whether there is enough of something. For two nutrients that turn up on almost every cognition label, the question runs the other way, and it is the easier one to act on.

What an upper intake level actually is

A tolerable upper intake level is not a dose and it is not a target. It is the highest daily intake likely to pose no risk of adverse effects for almost everyone, and going above it occasionally is not the same as harm.

What makes these two worth knowing is that they are the only two figures on a typical cognition panel that a shopper can push past by accident, because the same nutrients appear in several products at once.

Both figures are from the NIH Office of Dietary Supplements. They describe nutrients, not any particular product.

Where the B6 limit came from, and why Europe disagrees

The hundred-milligram figure is not arbitrary and it is not new. Chronic intakes of 1 to 6 g a day, taken for twelve to forty months, cause severe and progressive sensory neuropathy with ataxia; the severity tracks the dose and symptoms usually stop on discontinuation if they are caught early (ODS, vitamin B6).

The Food and Nutrition Board also notes several reports of sensory neuropathy at intakes below 500 mg a day, and it derived the 100 mg limit by halving the 200 mg average dose used in five-year studies. So the American limit is a halved figure taken from studies of much larger intakes, which is a conservative method and an old one.

Europe went a great deal further. In 2023 EFSA set an upper limit of 12 mg a day for all adults, including during pregnancy and lactation. That figure is reported on the NIH Office of Dietary Supplements’ own vitamin B6 fact sheet, which is where this desk read it.

Twelve and a hundred are not a rounding difference. Two regulators looking at broadly the same literature landed roughly eight times apart, which tells a reader that the uncertainty is real rather than settled, and it hands anyone who wants to be cautious a number to be cautious with.

Neither figure is a dose. Twelve milligrams is no more a target than a hundred is, and an upper limit is not a recommendation turned up loud. It is the ceiling on a running total.

Why niacinamide rather than nicotinic acid

Vitamin B3 comes in two supplement forms and they behave differently enough that a label naming which one it uses is telling you something real.

Nicotinic acid causes flushing at thirty to fifty milligrams or more: a hot, red, prickling sensation in the face and chest that is harmless and extremely noticeable. Nicotinamide, also called niacinamide, does not, because of a slight difference in chemical structure.

So a cognition label specifying niacinamide has chosen the form that does not produce a visible effect ten minutes after swallowing. That is a formulation decision about comfort, not about potency, and it is worth recognising rather than reading as either a plus or a minus.

What the niacin limit is protecting against

The 35 mg figure is set on the flushing threshold, and it was extended to the non-flushing form deliberately rather than by oversight. It applies to supplemental niacin in both forms, which is why the label’s choice of form does not move the ceiling.

Above that ceiling, the two forms have different problems, and the fact sheet keeps them apart. Nausea, vomiting and signs of liver toxicity can occur with nicotinamide intakes around 3,000 mg a day. High intakes of nicotinic acid taken over months or years can be hepatotoxic, and large doses of it can raise blood glucose. Those last two belong to nicotinic acid, and carrying them across to a niacinamide label would be the same error as carrying the flush across.

Notice the distance in that paragraph. The upper limit is 35 mg; the documented trouble with nicotinamide starts around 3,000. A tolerable upper intake level is not a cliff edge, and a single day slightly over it is not an injury. What it is good for is the running total over months, which is exactly the timescale a daily capsule operates on.

That is also why these two nutrients are worth more attention than the botanicals beside them on a cognition panel. Nobody stacks three products that all contain bacopa by accident. Stacking three that all contain B6 is ordinary.

The arithmetic, worked once

This is a five-minute job and it needs a pen rather than a search engine. Suppose a daily multivitamin prints 2 mg of vitamin B6 and a B-complex prints 50 mg. That is 52 mg before anything else is counted: comfortably inside the American limit of 100 mg, comfortably outside the European figure of 12 mg, and a useful thing to know about yourself.

Now add a third product that names vitamin B6 and prints no amount beside it. The total cannot be completed, and no honest arithmetic pretends otherwise. What you can still say is where the two products you can read have already put you, and that is usually enough to make a decision with.

1. Line up everything you take daily, including the ones you think of as food rather than supplements.
2. Copy out two numbers from each Supplement Facts panel: vitamin B6 in milligrams, and niacin in mg or mg NE.
3. Add each column. Compare the B6 total with 100 mg, and with 12 mg if you want the cautious European view. Compare the niacin total with 35 mg.
4. Note which products named a nutrient without printing an amount. Those are not zeros; they are unknowns, and the difference matters.
5. If the readable totals are already close to a limit, that is the conversation to have with a prescriber, and the reason to name everything you take when you have it.

The whole exercise uses only figures somebody chose to print. That is its virtue: it is the same answer you would reach with the missing numbers in hand, arrived at without them.

What the agency that looked says about B vitamins and memory

One more thing belongs here, because the two nutrients with upper limits are also the two most often sold as brain nutrients.

NCCIH’s own summary is that vitamin B6, vitamin B12 and folic acid have not been shown to improve cognitive functioning in older adults. Longer-term studies suggest a possible role in slowing decline, and that is as far as the sentence goes.

The same page carries a line that outranks everything else on this shelf: do not use a complementary approach as a reason to postpone seeing a provider about memory loss.

So the upper limits are the most useful numbers on a cognition panel not because they promise anything but because they are the only two a shopper can check. That is a modest job. It is also the only one on this label that a buyer can finish on their own.

What to do when a label prints no amounts

Plenty of labels on this shelf name their ingredients without printing a figure beside any of them. When that happens the upper-limit question cannot be answered from that label, and pretending otherwise helps nobody.

The practical move is the other direction. Count the products in your cupboard that do print amounts, add up their B6 and their niacin, and see how much headroom is left. That arithmetic uses only figures you can read, and it is the same answer you would reach with the missing numbers in hand.

It is also the conversation a prescriber can have with you, which is the other reason a list of names is worth more than nothing: supplements and medicines taken together can interact in ways that matter, and a name is what makes that check possible even when a quantity is missing.

It is worth knowing what a panel is obliged to carry, so you can tell a panel from a web page. 21 CFR 101.36 requires the quantitative amount by weight per serving of every dietary ingredient that is not one of the listed nutrients, and a proprietary blend that omits the individual figures must still declare its total weight. MedlinePlus is a reasonable ten-minute orientation on how supplements are regulated if none of this is familiar.

There is a second reason the panel on the bottle matters on this particular product. Two published documents describe it and they do not name the same ingredients; one of the two lists contains caffeine. This desk asserts neither as the contents, so the panel that arrives in the box is the document that answers both the upper-limit question and the stimulant one.

The ingredients page on this website sets out what published trials used for all eight names, in a column of its own; the label page prints both published lists side by side; and the safety page names the three groups of medicine worth raising first. Two other names on this label have a fuller page of their own: the actual trial behind a B vitamin on this list, and where huperzine A comes from before it is a capsule ingredient.